Liquid biopsies have significant potential to impact clinical trials and a large number of studies are in progress to prove clinical utility.
REGISTER BELOW to watch leading European KOLs discuss the current and future use of liquid biopsies and some success stories in clinical trials:
No cost to register; subject to confirmation.
By registering for this event, you accept that you may receive direct communication from the sponsor(s).
If you are experiencing problems with your registration, please try the Zoom registration page.
Chris Abbosh
Medical Oncology Clinician Scientist, UCL
Overview of the solid tumor MRD landscape
Thomas Powles
Director, Barts Cancer Center
IMvigor trial
Angel Rodriguez
Medical Director, Oncology, Natera
Tumor-informed MRD testing across cancer types
Naureen Starling
Principal Investigator, Royal Marsden Hospital
Liquid biopsies for faster diagnosis
Developed by Endpoints Studio © 2021